Melodia Therapeutics AG
PrivateLast Round
Series A
Sep 2, 2025
Company Overview
Melodia Therapeutics AG is a biotechnology company focused on developing oral therapies that target neutrophil-driven inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melodia Therapeutics AG Comparables
Compare Melodia Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insmed Incorporated | 75% | |
| Chiesi Farmaceutici S.p.A. | 74% | |
| Haisco Pharmaceutical Group | 74% | |
Melodia Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2025 | ||||
| Seed | Jun 1, 2024 |
Key People
Founding team and executive leadership
Melodia Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forty51 Ventures | Seed |
Melodia Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Melodia Therapeutics AG's valuation, stock price, and market status.